Figure 1. Grade III dermatitis after finishing the radiotherapy treatment.
| World Journal of Oncology, ISSN 1920-4531 print, 1920-454X online, Open Access |
| Article copyright, the authors; Journal compilation copyright, World J Oncol and Elmer Press Inc |
| Journal website http://www.wjon.org |
Case Report
Volume 2, Number 3, June 2011, pages 143-146
Grade III Dermatitis in a Patient Treated With Paclitaxel and Radiotherapy: Case Report and Review of the Literature
Figure
Table
| Studies | CAPE dose (mg/m2 twice daily from days 1 to 14 every 3 weeks) | Wpacli dose (mg/m2, days 1, 8 and 15) | No. of patients | Toxicity (Grade) |
|---|---|---|---|---|
| Di Constanzo F et al 2006 [4] | 1250 | 80 | 31 | Grade IV: one patient |
| Unlmann C et al 2005 [5] | 1000 | 80 | 15 | Reported generally |
| Gick U et al 2006 [6] | 825 | 80 | 55 | NR |
| Bari M et al 2005 [7] | 1000 | 60 | 33 | Grade I/II: 15% |
| Blum JL et al 2006 [8] | 1000 | 80 | 19 | NR (non reported) |
| Gradishar WJ et al 2004 [9] | 825 | 175 | 47 | NR |
| Kao J et al 2005 [12] | - | Dose escal.: 5 - 20 | 33 | Grade II/IV: 8 patients |
| Burstein H et al 2006 [13] | - | Weekly: 60 Every 3 weeks: 135 - 175 | 40 | Grade II: 2 patients |
| Chen W et al 2010 [14] | - | 175 | 44 | Grade I: 77.8% Grade II: 16.7% Grade III: 5.6% (2 patients) |
| Hanna Y et al 2002 [15] | - | 175 | 20 | Grade II: 65% (13 patients) |